abc biopply AG is pioneering NAM technologies and organoid CRO services that boost in vitro studies for drug discovery and development to IND relevance using its proprietary 3D CoSeedis Multi-Organoid in chip Technology™ on clinically relevant disease models (oncology, neurology, obesity and others)
Products, services, technology
abc biopply AG provides validated highly predictive preclinical CRO services for drug efficacy, safety, toxicity, resistance, and biomarker development based on its proprietary 3D CoSeedis humanized multi-organoid assays™ for immuno-oncology, neurology and others.
Cooperation possibilities
abc biopply's proprietary NAM technology allow the company to custom tailor or design any disease model for clients and than license it to them for in-house implementation and scale up.
abc biopply is also open to partners worldwide to strenghen its international Organoid Competence Center network.
- https://biopply.com
- +41 79 434 10 49
- Send an email
- Dr. Arne Faisst
